T3 RECEPTORS IN GENE REGULATION AND ONCOGENESIS
T3 RECEPTORS IN GENE REGULATION AND ONCOGENESIS
批准号:
2016157
负责人:
MAGNUS Pfahl PFAHL
金额:
$25.29万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-08-01 至 1997-11-30
关键词:
biological signal transduction dimer gel mobility shift assay gene induction /repression gene targeting genetic regulation genetic regulatory element hormone receptor hormone regulation /control mechanism molecular cloning oncogenes polymerase chain reaction protein structure function reporter genes retinoate transcription factor transfection triiodothyronine
中文摘要
甲状腺激素调节着一系列重要的生物反应
英文摘要
Thyroid hormones regulate a very large spectrum of important biological
processes including development, metamorphosis, growth, differentiation,
metabolism, and homeostasis. A central question has been how this large
array of programs can be regulated by a limited number of hormones and how
individual-responses can be restricted to certain cell types and
developmental stages. A detailed understanding of these mechanisms offers
elucidation of biological programs and optimal usage of these hormones and
their analogs in therapies.
Like the steroid hormones thyroid hormone (T3) signals are mediated by
nuclear receptors that belong to one of the largest transcription factor
families known today. The complexity of the thyroid hormone response is
displayed to some degree at the receptor level by two genes (TRalpha and
TRbeta) that give rise to multiple isoforms, some of which are not ligand
dependent transcriptional activators. Until recently it had been assumed
that TRs, like the steroid hormone receptors mainly function by one
"direct" pathway that involves binding of the receptors as homodimers to
specific DNA sequences. However, during the last two years our view on how
the receptors operate has changed dramatically. Recent results strongly
suggest that TRs require heterodimerization with Retinoid X Receptors
(RXRs) for effective DNA binding and function. Furthermore, TRs have been
found to regulate gene transcription by a novel "indirect" mechanism where
TRs interact with the transcription factor AP-l. AP-l mediates signal
transduction by growth factors, oncogenes, and the tumor promoter TPA. By
interfering with this pathway, TRs can function as anti-oncogenes.
In the coming years we will further analyze the basic mechanisms of TR
action to obtain a basis for understanding thyroid hormone action in the
normal and disease states. We will investigate the roles of TR homodimers
and heterodimers in the direct and indirect response pathways. The role
and function of TR carboxy terminal isoforms will also be analyzed
employing gene knockout technology and by identifying response elements
and co-receptors for these isoforms. To further understand on how TRs
mediate crosstalk between thyroid hormones and AP- l mediated signalling,
studies analyzing the molecular mechanism of TR-AP-1 interaction will be
carried out. The proposed research will further our understanding of gene
regulation and pathways controlled by TRs. These results will enhance our
knowledge of T3 action in normal physiological processes and disease.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ligand-binding domain of thyroid hormone receptors modulates DNA binding and determines their bifunctional roles.
甲状腺激素受体的配体结合域调节 DNA 结合并决定其双功能作用。
DOI:
--
发表时间:
1991
期刊:
The New biologist
影响因子:
--
作者:
[Zhang,XK, Wills,KN, Graupner,G, Tzukerman,M, Hermann,T, Pfahl,M]
通讯作者:
Pfahl,M
Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation.
视黄酸受体和 AP-1 之间的拮抗作用:对肿瘤促进和炎症的影响。
DOI:
--
发表时间:
1991
期刊:
The New biologist
影响因子:
--
作者:
[Yang-Yen,HF, Zhang,XK, Graupner,G, Tzukerman,M, Sakamoto,B, Karin,M, Pfahl,M]
通讯作者:
Pfahl,M
DNA binding and dimerization determinants for thyroid hormone receptor alpha and its interaction with a nuclear protein.
甲状腺激素受体α的DNA结合和二聚化决定因素及其与核蛋白的相互作用。
DOI:
10.1210/mend-5-12-1909
发表时间:
1991
期刊:
Molecular endocrinology (Baltimore, Md.)
影响因子:
--
作者:
[Zhang,XK, Tran,PB, Pfahl,M]
通讯作者:
Pfahl,M
Identification of retinoids with nuclear receptor subtype-selective activities.
鉴定具有核受体亚型选择性活性的类维生素A。
DOI:
--
发表时间:
1991
期刊:
Cancer research
影响因子:
11.2
作者:
[Lehmann,JM, Dawson,MI, Hobbs,PD, Husmann,M, Pfahl,M]
通讯作者:
Pfahl,M
Heterodimeric receptor complexes determine 3,5,3'-triiodothyronine and retinoid signaling specificities.
异二聚体受体复合物决定 3,5,3-三碘甲状腺原氨酸和类视黄醇信号传导特异性。
DOI:
10.1210/mend.6.7.1324421
发表时间:
1992
期刊:
Molecular endocrinology (Baltimore, Md.)
影响因子:
--
作者:
[Hermann,T, Hoffmann,B, Zhang,XK, Tran,P, Pfahl,M]
通讯作者:
Pfahl,M
共 18 条
New ultra-selective kinase inhibitors for the treatment of AML
-
批准号:8313208
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2012
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
ANALYSIS OF RETINOID MEDIATED ANTI-CANCER ACTIVITIES
-
批准号:3200194
-
项目类别:
-
资助金额:$24.34万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
-
批准号:2096800
-
项目类别:
-
资助金额:$26.55万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
-
批准号:2700471
-
项目类别:
-
资助金额:$28.13万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
Analysis of Retinoid Mediated Anti Cancer Activities
-
批准号:6512729
-
项目类别:
-
资助金额:$32.93万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
-
批准号:2414232
-
项目类别:
-
资助金额:$27.41万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
-
批准号:2096798
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
Analysis of Retinoid Mediated Anti Cancer Activities
-
批准号:6328484
-
项目类别:
-
资助金额:$28.58万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
-
批准号:2096799
-
项目类别:
-
资助金额:$26.53万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
ANALYSIS OF RETINOID MEDIATED ANTI-CANCER ACTIVITIES
-
批准号:3200193
-
项目类别:
-
资助金额:$23.12万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOID MEDIATED ANTICANCER ACTIVITIES
-
批准号:2894913
-
项目类别:
-
资助金额:$28.96万
-
财政年份:1992
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOIC ACID RECEPTOR IN DEVELOPMENT AND DISEASE
-
批准号:3195326
-
项目类别:
-
资助金额:$19.27万
-
财政年份:1990
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOIC ACID RECEPTOR IN DEVELOPMENT AND DISEASE
-
批准号:3195325
-
项目类别:
-
资助金额:$18.14万
-
财政年份:1990
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOIC ACID RECEPTOR IN DEVELOPMENT AND DISEASE
-
批准号:3195327
-
项目类别:
-
资助金额:$19.85万
-
财政年份:1990
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOIC ACID RECEPTOR IN DEVELOPMENT AND DISEASE
-
批准号:3195324
-
项目类别:
-
资助金额:$16.39万
-
财政年份:1990
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
RETINOIC ACID RECEPTOR IN DEVELOPMENT AND DISEASE
-
批准号:2093923
-
项目类别:
-
资助金额:$19.39万
-
财政年份:1990
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
CLONING AND ANALYSIS OF STEROID RECEPTOR GENES
-
批准号:3233317
-
项目类别:
-
资助金额:$24.73万
-
财政年份:1987
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
T3 RECEPTORS IN GENE REGULATION AND ONCOGENESIS
-
批准号:2139474
-
项目类别:
-
资助金额:$23.03万
-
财政年份:1987
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
CLONING AND ANALYSIS OF STEROID RECEPTOR GENES
-
批准号:3233321
-
项目类别:
-
资助金额:$28.78万
-
财政年份:1987
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
CLONING AND ANALYSIS OF STEROID RECEPTOR GENES
-
批准号:3233320
-
项目类别:
-
资助金额:$28.3万
-
财政年份:1987
-
负责人:MAGNUS Pfahl PFAHL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
超高亲和力、高亮度 Dimer 荧光 RNA 探针用于活细胞 RNA 单分子成像
-
批准号:24ZR1432500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:蒋丽
-
依托单位:
靶向肝细胞癌glypican-3的新型68Ga/177Lu-DOTA-3PEGn-TJ12P2 Dimer诊疗一体化探针的初步研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:朱冬灵
-
依托单位:
血浆D-dimer检测恶性肿瘤血行微转移的临床价值评估及机制研究
-
批准号:81501826
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:刁冬梅
-
依托单位:
Dimer 系统的非平衡统计问题
-
批准号:10175008
-
项目类别:面上项目
-
资助金额:13.0万元
-
批准年份:2001
-
负责人:杨展如
-
依托单位: